Caxton Associates (New York)’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-79,344	Closed	-$3.07M	–	519
2024 Q3	$3.07M	Buy	79,344 +25,733	+48%	+$994K	0.11%	63
2024 Q2	$1.73M	Buy	53,611 +9,046	+20%	+$291K	0.06%	166
2024 Q1	$1.73M	Buy	+44,565	New	+$1.73M	0.1%	143